- Home
- Publications
- Publication Search
- Publication Details
Title
Towards new therapeutic approaches for malignant melanoma
Authors
Keywords
-
Journal
EXPERT REVIEWS IN MOLECULAR MEDICINE
Volume 13, Issue -, Pages -
Publisher
Cambridge University Press (CUP)
Online
2011-11-01
DOI
10.1017/s146239941100202x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Endogenous Retrovirus (HERV-K) Reverse Transcriptase as a Breast Cancer Prognostic Marker
- (2015) Maya Golan et al. NEOPLASIA
- Growth-Inhibitory and Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with or without BRAF Mutations
- (2015) Ludovica Ciuffreda et al. NEOPLASIA
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- Targeting BRAF in Advanced Melanoma: A First Step toward Manageable Disease
- (2011) A. Vultur et al. CLINICAL CANCER RESEARCH
- Immunotherapy for melanoma
- (2011) Jeffrey Weber CURRENT OPINION IN ONCOLOGY
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab
- (2011) Vernon K. Sondak et al. NATURE REVIEWS DRUG DISCOVERY
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
- (2011) C. Garbe et al. ONCOLOGIST
- Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
- (2010) Christopher D. Porada et al. ADVANCED DRUG DELIVERY REVIEWS
- Remotely Triggerable Drug Delivery Systems
- (2010) Brian P. Timko et al. ADVANCED MATERIALS
- MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
- (2010) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- BRAF as therapeutic target in melanoma
- (2010) Claudia Wellbrock et al. BIOCHEMICAL PHARMACOLOGY
- Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics
- (2010) Scott E. Woodman et al. BIOCHEMICAL PHARMACOLOGY
- High-throughput miRNA profiling of human melanoma blood samples
- (2010) Petra Leidinger et al. BMC CANCER
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
- (2010) D Handolias et al. BRITISH JOURNAL OF CANCER
- BRAF, a target in melanoma
- (2010) Keith T. Flaherty et al. CANCER
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
- (2010) Cathrine L. Denton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
- (2010) H. Yang et al. CANCER RESEARCH
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
- (2010) Lyndee L. Scurr et al. CELL
- Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
- (2010) M. F. Segura et al. CLINICAL CANCER RESEARCH
- The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
- (2010) U. Banerji et al. CLINICAL CANCER RESEARCH
- Mutation-driven drug development in melanoma
- (2010) Keith T Flaherty et al. CURRENT OPINION IN ONCOLOGY
- Potential clinical applications of siRNA technique: benefits and limitations
- (2010) Shao-Hua Chen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery
- (2010) Claire M Cobley et al. Expert Opinion on Drug Delivery
- PLX4032: does it keep its promise for metastatic melanoma treatment?
- (2010) Elisabeth Livingstone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Testing the divergent pathway hypothesis for melanoma: recent findings and future challenges
- (2010) David C Whiteman Expert Review of Anticancer Therapy
- Targeted Nanoparticles Deliver siRNA to Melanoma
- (2010) Yunching Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics
- (2010) Long Xu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
- (2010) S. Mocellin et al. JNCI-Journal of the National Cancer Institute
- Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
- (2010) Luca Sigalotti et al. Journal of Translational Medicine
- Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy
- (2010) C. K. Augustine et al. MOLECULAR CANCER THERAPEUTICS
- Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma
- (2010) Carmit Levy et al. MOLECULAR CELL
- pH-Responsive Nanoparticles for Drug Delivery
- (2010) Weiwei Gao et al. MOLECULAR PHARMACEUTICS
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
- (2010) F M Kaplan et al. ONCOGENE
- Analysis of the genome to personalize therapy for melanoma
- (2010) M A Davies et al. ONCOGENE
- P504S expressing circulating prostate cells as a marker for prostate cancer
- (2010) Murray ONCOLOGY REPORTS
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy of Melanoma: An Update
- (2010) Jade Homsi et al. Surgical Oncology Clinics of North America
- Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme
- (2010) Margarita Gutova et al. Current Stem Cell Research & Therapy
- Epidemiology of invasive cutaneous melanoma
- (2009) R. M. MacKie et al. ANNALS OF ONCOLOGY
- The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine
- (2009) Aws Alshamsan et al. BIOMATERIALS
- Integrating BRAF/MEK inhibitors into combination therapy for melanoma
- (2009) K S M Smalley et al. BRITISH JOURNAL OF CANCER
- Role of miRNAs in the progression of malignant melanoma
- (2009) D W Mueller et al. BRITISH JOURNAL OF CANCER
- The role of human endogenous retroviruses in melanoma
- (2009) S. Singh et al. BRITISH JOURNAL OF DERMATOLOGY
- Simultaneous Inhibition of MEK and CDK4 Leads to Potent Apoptosis in Human Melanoma Cells
- (2009) Jing Li et al. CANCER INVESTIGATION
- Systemic Therapy for Cutaneous Melanoma
- (2009) Jonathan Treisman et al. CLINICS IN PLASTIC SURGERY
- The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation
- (2009) A. Serafino et al. EXPERIMENTAL CELL RESEARCH
- Driving in the melanoma landscape
- (2009) Meenhard Herlyn EXPERIMENTAL DERMATOLOGY
- Applications of Genomics in Melanoma Oncogene Discovery
- (2009) Michael F. Berger et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Imatinib Mesylate Depends on the Presence of the V559A-Mutated KIT Oncogene
- (2009) Patrick Terheyden et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- KIT as a Therapeutic Target in Melanoma
- (2009) Maria C. Garrido et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Multimodal drug delivery using gold nanoparticles
- (2009) Chae-kyu Kim et al. Nanoscale
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- Use of liposomes as drug delivery vehicles for treatment of melanoma
- (2009) Melissa A. Tran et al. Pigment Cell & Melanoma Research
- RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway
- (2009) Angela M. Keuling et al. PLoS One
- Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
- (2009) S. Basu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma Drug Vindicates Targeted Approach
- (2009) K. Garber SCIENCE
- Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles
- (2009) Baozhong Zhao et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Serological Response to Human Endogenous Retrovirus K in Melanoma Patients Correlates with Survival Probability
- (2008) Silvia Hahn et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis
- (2008) Yanhua Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
- (2008) K. Porkka et al. BLOOD
- Phase II trial of imatinib mesylate in patients with metastatic melanoma
- (2008) K B Kim et al. BRITISH JOURNAL OF CANCER
- A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis
- (2008) Juan Su et al. CANCER LETTERS
- Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development
- (2008) M. A. Tran et al. CANCER RESEARCH
- Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA
- (2008) Gabriel J. Villares et al. CANCER RESEARCH
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
- (2008) Thomas Kuilman et al. CELL
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7
- (2008) Narendra Wajapeyee et al. CELL
- A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel
- (2008) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development
- (2008) M. A. Tran et al. CLINICAL CANCER RESEARCH
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma
- (2008) X. Jiang et al. CLINICAL CANCER RESEARCH
- Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate
- (2008) U. B. Hofmann et al. CLINICAL CANCER RESEARCH
- Melanoma epidemiology and trends
- (2008) Claus Garbe et al. CLINICS IN DERMATOLOGY
- Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?
- (2008) Paul Lorigan et al. EXPERIMENTAL DERMATOLOGY
- Stem and progenitor cell-mediated tumor selective gene therapy
- (2008) K S Aboody et al. GENE THERAPY
- Nonsolar occupational risk factors for cutaneous melanoma
- (2008) Cristina Fortes et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- MicroRNA and cancer - focus on apoptosis
- (2008) Yu Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells
- (2008) Konstantinos G. Lasithiotakis et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melanoma Genetics and Therapeutic Approaches in the 21st Century: Moving from the Benchside to the Bedside
- (2008) Thomas L. Hocker et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Proliferation Arrest in B-Raf Mutant Melanoma Cell Lines upon MAPK Pathway Activation
- (2008) Roland Houben et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas
- (2008) K. S.M. Smalley et al. MOLECULAR CANCER THERAPEUTICS
- Widespread changes in protein synthesis induced by microRNAs
- (2008) Matthias Selbach et al. NATURE
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
- Understanding Signaling Cascades in Melanoma
- (2008) Pablo Lopez-Bergami et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
- (2008) Jose Lutzky et al. Pigment Cell & Melanoma Research
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now